Table of Content

1. Introduction


2. Research Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. US Pain Management Therapeutics Market


6. Market Share – US Pain Management Therapeutics Market

6.1 By Therapeutics
6.2 By Devices
6.3 By Drug Class
6.4 By Indication
6.5 By Pain Type


7. Therapeutics – US Pain Management Therapeutics Market

7.1 Pharmaceuticals
7.2 Devices


8. Devices – US Pain Management Therapeutics Market

8.1 Electrical Stimulators
8.2 Radiofrequency Ablation
8.3 Analgesic Infusion Pumps
8.4 Neurostimulation


9. Drug Class – US Pain Management Therapeutics Market

9.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
9.2 Anesthetics
9.3 Anticonvulsants
9.4 Anti-Migraine Agents
9.5 Antidepressants
9.6 Opioids
9.7 Nonnarcotic Analgesics


10. Indication – US Pain Management Therapeutics Market

10.1 Arthritic Pain
10.2 Neuropathic Pain
10.3 Cancer Pain
10.4 Chronic Back Pain
10.5 Post-Operative Pain
10.6 Migraine
10.7 Fibromyalgia
10.8 Bone Fracture
10.9 Muscle Sprain/Strain
10.10 Acute Appendicitis
10.11 Others


11. Pain Type – US Pain Management Therapeutics Market

11.1 Chronic Pain
11.2 Acute Pain


12. Porter’s Five Forces Analysis

12.1 Threat of New Entry
12.2 The Bargaining Power of Buyer
12.3 Threat of Substitution
12.4 The Bargaining Power of Supplier
12.5 Competitive Rivalry


13. Company Analysis

13.1 Eli Lilly and Company

13.1.1 Overview
13.1.2 Recent Development
13.1.3 Financial Insight

13.2 Pfizer Inc.

13.2.1 Overview
13.2.2 Recent Development
13.2.3 Financial Insight

13.3 GlaxoSmithKline plc

13.3.1 Overview
13.3.2 Recent Development
13.3.3 Financial Insight

13.4 Novartis International AG

13.4.1 Overview
13.4.2 Recent Development
13.4.3 Financial Insight

13.5 Merck & Co., Inc.

13.5.1 Overview
13.5.2 Recent Development
13.5.3 Financial Insigh

13.6 Abbott Laboratories

13.6.1 Overview
13.6.2 Recent Development
13.6.3 Financial Insight

13.7 Johnson & Johnson

13.7.1 Overview
13.7.2 Recent Development
13.7.3 Financial Insight

13.8 Boehringer Ingelheim

13.8.1 Overview
13.8.2 Recent Development
13.8.3 Financial Insight



List of Figures

Figure-01: United States – Pain Management Therapeutics Market (Billion US$), 2018 – 2021
Figure-02: United States – Forecast for Pain Management Therapeutics Market (Billion US$), 2022 – 2027
Figure-03: Therapeutics – Pharmaceuticals Market (Billion US$), 2018 – 2021
Figure-04: Therapeutics – Forecast for Pharmaceuticals Market (Billion US$), 2022 – 2027
Figure-05: Therapeutics – Devices Market (Billion US$), 2018 – 2021
Figure-06: Therapeutics – Forecast for Devices Market (Billion US$), 2022 – 2027
Figure-07: Devices – Electrical Stimulators Market (Million US$), 2018 – 2021
Figure-08: Devices – Forecast for Electrical Stimulators Market (Million US$), 2022 – 2027
Figure-09: Devices – Radiofrequency Ablation Market (Million US$), 2018 – 2021
Figure-10: Devices – Forecast for Radiofrequency Ablation Market (Million US$), 2022 – 2027
Figure-11: Devices – Analgesic Infusion Pumps Market (Million US$), 2018 – 2021
Figure-12: Devices – Forecast for Analgesic Infusion Pumps Market (Million US$), 2022 – 2027
Figure-13: Devices – Neurostimulation Market (Billion US$), 2018 – 2021
Figure-14: Devices – Forecast for Neurostimulation Market (Billion US$), 2022 – 2027
Figure-15: Drug Class – Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market (Billion US$), 2018 – 2021
Figure-16: Drug Class – Forecast for Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market (Billion US$), 2022 – 2027
Figure-17: Drug Class – Anesthetics Market (Billion US$), 2018 – 2021
Figure-18: Drug Class – Forecast for Anesthetics Market (Billion US$), 2022 – 2027
Figure-19: Drug Class – Anticonvulsants Market (Billion US$), 2018 – 2021
Figure-20: Drug Class – Forecast for Anticonvulsants Market (Billion US$), 2022 – 2027
Figure-21: Drug Class – Anti-Migraine Agents Market (Billion US$), 2018 – 2021
Figure-22: Drug Class – Forecast for Anti-Migraine Agents Market (Billion US$), 2022 – 2027
Figure-23: Drug Class – Antidepressants Market (Billion US$), 2018 – 2021
Figure-24: Drug Class – Forecast for Antidepressants Market (Billion US$), 2022 – 2027
Figure-25: Drug Class – Opioids Market (Billion US$), 2018 – 2021
Figure-26: Drug Class – Forecast for Opioids Market (Billion US$), 2022 – 2027
Figure-27: Drug Class – Nonnarcotic Analgesics Market (Billion US$), 2018 – 2021
Figure-28: Drug Class – Forecast for Nonnarcotic Analgesics Market (Billion US$), 2022 – 2027
Figure-29: Indication – Arthritic Pain Market (Billion US$), 2018 – 2021
Figure-30: Indication – Forecast for Arthritic Pain Market (Billion US$), 2022 – 2027
Figure-31: Indication – Neuropathic Pain Market (Billion US$), 2018 – 2021
Figure-32: Indication – Forecast for Neuropathic Pain Market (Billion US$), 2022 – 2027
Figure-33: Indication – Cancer Pain Market (Billion US$), 2018 – 2021
Figure-34: Indication – Forecast for Cancer Pain Market (Billion US$), 2022 – 2027
Figure-35: Indication – Chronic Back Pain Market (Billion US$), 2018 – 2021
Figure-36: Indication – Forecast for Chronic Back Pain Market (Billion US$), 2022 – 2027
Figure-37: Indication – Post-Operative Pain Market (Billion US$), 2018 – 2021
Figure-38: Indication – Forecast for Post-Operative Pain Market (Billion US$), 2022 – 2027
Figure-39: Indication – Migraine Market (Billion US$), 2018 – 2021
Figure-40: Indication – Forecast for Migraine Market (Billion US$), 2022 – 2027
Figure-41: Indication – Fibromyalgia Market (Billion US$), 2018 – 2021
Figure-42: Indication – Forecast for Fibromyalgia Market (Billion US$), 2022 – 2027
Figure-43: Indication – Bone Fracture Market (Million US$), 2018 – 2021
Figure-44: Indication – Forecast for Bone Fracture Market (Million US$), 2022 – 2027
Figure-45: Indication – Muscle Sprain/Strain Market (Million US$), 2018 – 2021
Figure-46: Indication – Forecast for Muscle Sprain/Strain Market (Million US$), 2022 – 2027
Figure-47: Indication – Acute Appendicitis Market (Million US$), 2018 – 2021
Figure-48: Indication – Forecast for Acute Appendicitis Market (Million US$), 2022 – 2027
Figure-49: Indication – Others Market (Billion US$), 2018 – 2021
Figure-50: Indication – Forecast for Others Market (Billion US$), 2022 – 2027
Figure-51: Pain Type – Chronic Pain Market (Billion US$), 2018 – 2021
Figure-52: Pain Type – Forecast for Chronic Pain Market (Billion US$), 2022 – 2027
Figure-53: Pain Type – Acute Pain Market (Billion US$), 2018 – 2021
Figure-54: Pain Type – Forecast for Acute Pain Market (Billion US$), 2022 – 2027
Figure-55: Eli Lilly and Company – Global Revenue (Billion US$), 2018 – 2021
Figure-56: Eli Lilly and Company – Forecast for Global Revenue (Billion US$), 2022 – 2027
Figure-57: Pfizer Inc. – Global Revenue (Billion US$), 2018 – 2021
Figure-58: Pfizer Inc. – Forecast for Global Revenue (Billion US$), 2022 – 2027
Figure-59: GlaxoSmithKline plc – Global Revenue (Billion US$), 2018 – 2021
Figure-60: GlaxoSmithKline plc – Forecast for Global Revenue (Billion US$), 2022 – 2027
Figure-61: Novartis International AG – Global Revenue (Billion US$), 2018 – 2021
Figure-62: Novartis International AG – Forecast for Global Revenue (Billion US$), 2022 – 2027
Figure-63: Merck & Co., Inc. – Global Revenue (Billion US$), 2018 – 2021
Figure-64: Merck & Co., Inc. – Forecast for Global Revenue (Billion US$), 2022 – 2027
Figure-65: Abbott Laboratories – Global Revenue (Billion US$), 2018 – 2021
Figure-66: Abbott Laboratories – Forecast for Global Revenue (Billion US$), 2022 – 2027
Figure-67: Johnson & Johnson – Global Revenue (Billion US$), 2018 – 2021
Figure-68: Johnson & Johnson – Forecast for Global Revenue (Billion US$), 2022 – 2027
Figure-69: Boehringer Ingelheim – Global Revenue (Billion US$), 2018 – 2021
Figure-70: Boehringer Ingelheim – Forecast for Global Revenue (Billion US$), 2022 – 2027

List of Tables

Table-01: United States Pain Management Therapeutics Market Share by Therapeutics (Percent), 2018 – 2021
Table-02: Forecast for – United States Pain Management Therapeutics Market Share by Therapeutics (Percent), 2022 – 2027
Table-03: United States Pain Management Therapeutics Market Share by Devices (Percent), 2018 – 2021
Table-04: Forecast for – United States Pain Management Therapeutics Market Share by Devices (Percent), 2022 – 2027
Table-05: United States Pain Management Therapeutics Market Share by Drug Class (Percent), 2018 – 2021
Table-06: Forecast for – United States Pain Management Therapeutics Market Share by Drug Class (Percent), 2022 – 2027
Table-07: United States Pain Management Therapeutics Market Share by Indication (Percent), 2018 – 2021
Table-08: Forecast for – United States Pain Management Therapeutics Market Share by Indication (Percent), 2022 – 2027
Table-09: United States Pain Management Therapeutics Market Share by Pain Type (Percent), 2018 – 2021
Table-10: Forecast for – United States Pain Management Therapeutics Market Share by Pain Type (Percent), 2022 – 2027